New Delhi, May 19: Mansukh Mandaviya, Minister of State for Chemicals and Fertilisers, on Wednesday said the Government is monitoring the supply of each COVID-19 essential drug.
All drugs used in the management of COVID-19 are now available in India by ramping up production and increasing the imports, a statement by the Ministry of Chemical and Fertilisers quoted Mr Mandaviya as saying.
The availability of these drugs is being monitored by implementing the three-pronged strategy of Supply Chain Management, Demand Side Management and Affordability.
The Central Drugs Standard Control Organisation (CDSCO) and the National Pharmaceutical Pricing Authority (NPPA) are coordinating with manufacturers to enhance production and getting data about current stock, current capacities, projected production for May 2021.
He noted that the number of plants producing Remdesivir increased from 20 to 60, leading to three times more availability in just 25 days.
‘Production ramped up 10 times, from 10 lakhs vials/month in April’21 to 1 crore/ month in May’21,’ he claimed.
Mr Mandaviya noted that production of Enoxaparin Injection, Methylprednisolone Injection, Ivermectin (12 mg) tablet, Favirpiravir, and Amphotericin B Injection has also been ramped up.
He said Toscilizumab injection is made available in the country by importing 20 times more than what was being done in normal times.
Besides, production of Dexamethasone 0.5 mg tablets enhanced from 6-8 times within a month, he said.
